Shadreck Mareya Selected Research

Lubiprostone

1/2022	Lubiprostone for Pediatric Functional Constipation: Randomized, Controlled, Double-Blind Study With Long-term Extension.
11/2021	Safety of Lubiprostone in Pediatric Patients With Functional Constipation: A Nonrandomized, Open-Label Trial.
6/2021	Correction to: Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation.
1/2021	Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation.
1/2018	Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shadreck Mareya Research Topics

Disease

4	Constipation 01/2022 - 01/2021
1	Opioid-Induced Constipation 01/2018
1	Diarrhea 01/2018
1	Nausea 01/2018
1	Pain (Aches) 01/2018
1	Ulcerative Colitis 06/2009
1	Hemorrhage 06/2009

Drug/Important Bio-Agent (IBA)

5	Lubiprostone FDA Link 01/2022 - 01/2018
2	Capsules (Microcapsules)IBA 06/2021 - 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2018
1	TabletsIBA 06/2009
1	balsalazide (Colazal)FDA LinkGeneric 06/2009

Therapy/Procedure

1	Therapeutics 01/2018